Multiple people across the globe who stepped forward are speaking about what they say is the debilitating aftermath they now ...

Recently, antivaxxers have been expressing their impatience with HHS Secretary Robert F. Kennedy Jr.'s progress eliminating ...

Pennsylvania’s short-term politics threaten its biotech future, driving innovation and opportunity to rival states.

Background Immunogenicity to SARS-CoV-2 vaccination in patients with SLE varies by vaccine type and immune-modulating therapy. However, data in Southeast Asian populations, especially among Thai ...

The oropharyngeal cancer market is anticipated to grow during the forecast period (2025--2034), driven by the launch of emerging therapies such as PDS Biotechnology's Versamune HPV, Inovio ...

Pfizer is now focusing on revving up its pipeline as CEO Albert Bourla sets his sights on an extra $20 billion in revenue by ...

Moderna stock has reached day 5 of a consecutive winning streak, with total gains during this time reaching a 13% return.

The U.S. Food and Drug Administration is yet to authorize the two modified boosters, for which applications were submitted ...

Earnings results often indicate what direction a company will take in the months ahead. With Q3 behind us, let’s have a look ...